Failure to control conventional cardiovascular risk factors in women with type 2 diabetes might explain worse mortality.
cohort
female
male
mortality
risk factors
type 2 diabetes
Journal
Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
10
05
2023
received:
31
12
2022
accepted:
03
07
2023
medline:
3
11
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
ppublish
Résumé
The standardised mortality rate (SMR) for people with diabetes in England is 1.5-1.7, with differences in outcomes between sexes. There has been little work examining the factors that could have an impact on this or on what may determine sex differences in outcome. Data were extracted for patients with type 2 diabetes (T2D) in Salford (England) in 2010 for the years up to 2020, including any deaths recorded. Expected deaths were calculated from annual Office of National Statistics mortality rate and life expectancy by age and gender, adjusted for the local Index of Multiple Deprivation (IMD). This provided the SMR deprivation (SMRd), and life expectancy years lost per death (LEYLD). The effects of treatment type, and clinical features on SMRd relative to sex were examined by univariable and multivariable analysis. Data from n = 11,806 (F = 5184; M = 6622) patients were included. Of these, n = 5540 were newly diagnosed and n = 3921 died (F = 1841; M = 2080). In total, n = 78,930 patient years. The expected deaths numbered n = 2596 (adjusted for age, sex, and IMD). Excess deaths were n = 1325 (F = 689; M = 636). Life expectancy years lost (LEYL) 18,989 (F = 9714; M = 9275). SMRd 1.51 (F = 1.60; M = 1.44) and LEYLD 4.84 years (F = 5.28; M = 4.46). The impact of risk factors was not different by sex. However, women had higher prevalence of % diagnosed >65 years of age; % last eGFR <60 mLs/min/1.73 m Outcomes in women with T2DM are worse than in men, contributed to by greater prevalence of adverse factors and less prescribing of cardioprotective medication.
Substances chimiques
Angiotensin Receptor Antagonists
0
Angiotensin-Converting Enzyme Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3695Informations de copyright
© 2023 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Références
Heald AH, Stedman M, Laing I, Gibson M, Whyte M. Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohort. Cardiovasc Endocrinol Metab. 2023;12(1):e0276. https://doi.org/10.1097/XCE.0000000000000276
Hendriks SH, van Hateren KJJ, Groenier KH, et al. Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50). BMJ Open. 2017;7(10):e015870. https://doi.org/10.1136/bmjopen-2017-015870
Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73-78. https://doi.org/10.1136/bmj.38678.389583.7C
Huxley RR, Peters SA, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(3):198-206. https://doi.org/10.1016/S2213-8587(14)70248-7
Mansour O, Golden SH, Yeh HC. Disparities in mortality among adults with and without diabetes by sex and race. J Diabetes Complications. 2020;34(3):107496. https://doi.org/10.1016/j.jdiacomp.2019.107496
Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542-1551. https://doi.org/10.1007/s00125-014-3260-6
Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383(9933):1973-1980. https://doi.org/10.1016/S0140-6736(14)60040-4
Prospective Studies C, Asia Pacific Cohort Studies C, Halsey J, et al. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol. 2018;6(7):538-546. https://doi.org/10.1016/S2213-8587(18)30079-2
National Diabetes Audit - Report 2 Complications and Mortality, 2017. Accessed 20 December 2022. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-2--complications-and-mortality-2017-18
Heald A, Stedman M, Robinson A, et al. Mortality rate associated with diabetes: outcomes from a general practice level analysis in England Using the Royal College of General Practitioners (RCGP) database indicate stability over a 15 Year period. Diabetes Ther. 2022;13(3):505-516. https://doi.org/10.1007/s13300-022-01215-1
Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;369(3):287-288. https://doi.org/10.1056/NEJMc1306652
Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115(1):114-126. https://doi.org/10.1161/CIRCULATIONAHA.106.179294
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580-591. https://doi.org/10.1056/NEJMoa0706245
Gregg EW, Williams DE, Geiss L. Changes in diabetes-related complications in the United States. N Engl J Med. 2014;371(3):286-287. https://doi.org/10.1056/NEJMc1406009
Wang Y, O'Neil A, Jiao Y, et al. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med. 2019;17(1):136. https://doi.org/10.1186/s12916-019-1355-0
Zhao M, Woodward M, Vaartjes I, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(11):e014742. https://doi.org/10.1161/JAHA.119.014742
Koopman C, Vaartjes I, Heintjes EM, et al. Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010. Eur Heart J. 2013;34(41):3198-3205. https://doi.org/10.1093/eurheartj/eht368
Zhao M, Vaartjes I, Graham I, et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart. 2017;103(20):1587-1594. https://doi.org/10.1136/heartjnl-2017-311429
Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27(12):2898-2904. https://doi.org/10.2337/diacare.27.12.2898
Peters SA, Huxley RR, Sattar N, Woodward M. Sex differences in the excess risk of cardiovascular diseases associated with type 2 diabetes: potential explanations and clinical implications. Curr Cardiovasc Risk Rep. 2015;9(7):36. https://doi.org/10.1007/s12170-015-0462-5
Wannamethee SG, Papacosta O, Lawlor DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia. 2012;55(1):80-87. https://doi.org/10.1007/s00125-011-2284-4
Integrated Care in Greater Manchester. Accessed 15 September 2022. https://www.salfordccg.nhs.uk/about-us/how
Bertram MY, Vos T. Quantifying the duration of pre-diabetes. Aust N Z J Publ Health. 2010;34(3):311-314. https://doi.org/10.1111/j.1753-6405.2010.00532.x
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278-316. https://doi.org/10.1210/er.2015-1137
Kaul P, Chu LM, Dover DC, Yeung RO, Eurich DT, Butalia S. Disparities in adherence to diabetes screening guidelines among males and females in a universal care setting: a population-based study of 1,380,697 adults. Lancet Reg Health Am. 2022;14:100320. https://doi.org/10.1016/j.lana.2022.100320
Peters SA, Huxley RR, Woodward M. Sex differences in body anthropometry and composition in individuals with and without diabetes in the UK Biobank. BMJ Open. 2016;6(1):e010007. https://doi.org/10.1136/bmjopen-2015-010007
Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JEB. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761-1772. https://doi.org/10.1007/s00125-019-4939-5
Woodward M, Peters SA, Huxley RR. Diabetes and the female disadvantage. Womens Health (Lond). 2015;11(6):833-839. https://doi.org/10.2217/whe.15.67
Logue J, Walker JJ, Colhoun HM, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 2011;54(12):3003-3006. https://doi.org/10.1007/s00125-011-2313-3
Paul S, Thomas G, Majeed A, Khunti K, Klein K. Women develop type 2 diabetes at a higher body mass index than men. Diabetologia. 2012;55(5):1556-1557. https://doi.org/10.1007/s00125-012-2496-2
Tunstall-Pedoe H, Woodward M, Tavendale R, Brook RA, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315(7110):722-729. https://doi.org/10.1136/bmj.315.7110.722
Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2008;31(7):1389-1391. https://doi.org/10.2337/dc08-0194
Patel KV, Bahnson JL, Gaussoin SA, et al. Association of baseline and longitudinal changes in body composition measures with risk of heart failure and myocardial infarction in type 2 diabetes: findings from the look AHEAD trial. Circulation. 2020;142(25):2420-2430. https://doi.org/10.1161/CIRCULATIONAHA.120.050941
Piani F, Melena I, Tommerdahl KL, et al. Sex-related differences in diabetic kidney disease: a review on the mechanisms and potential therapeutic implications. J Diabetes Complications. 2021;35(4):107841. https://doi.org/10.1016/j.jdiacomp.2020.107841
Shen Y, Cai R, Sun J, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017;55(1):66-76. https://doi.org/10.1007/s12020-016-1014-6
Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care. 2004;27(6):1330-1334. https://doi.org/10.2337/diacare.27.6.1330
Nuffield Department of Population Health Renal Studies Group, SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trial Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801. https://doi.org/10.1016/S0140-6736(22)02074-8
White MC, Fleeman R, Arnold AC. Sex differences in the metabolic effects of the renin-angiotensin system. Biol Sex Differ. 2019;10(1):31. https://doi.org/10.1186/s13293-019-0247-5